StonvexLoading…
StonvexStonvexStonvexCore line items from MHK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.79B | $10.84B | $11.14B | $11.74B |
Operating Income | $489.80M | $693.50M | $-291.90M | $244.20M |
Net Income | $369.90M | $514.70M | $-449.00M | $25.20M |
EPS (Diluted) | $5.93 | $8.09 | $-7.05 | $0.39 |
Total Assets | $13.69B | $12.74B | $13.52B | $14.12B |
Total Liabilities | $5.31B | $5.22B | $5.93B | $6.10B |
Cash & Equivalents | $856.10M | $666.60M | $642.60M | $509.62M |
Free Cash Flow OCF − CapEx | $616.20M | $679.50M | $716.30M | $88.50M |
Shares Outstanding | 62.40M | 63.60M | 71.02M | 70.88M |